Neximmune, Inc.
SEC CIK 1538210 · NEXI · last insider filing 2024-06-13
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Jones Kristi | Director · President and CEO | filed 2021 - 2024 |
| Roemer Alan S. | Director | filed 2021 - 2023 |
| Barer SOL J | Director | filed 2021 - 2023 |
| Yao Zhengbin | Director | filed 2021 - 2023 |
| Bertram Timothy | Director | filed 2021 - 2023 |
| D'Angio Paul | Director | filed 2021 - 2023 |
| Verstandig Grant | Director | filed 2021 - 2023 |
| Gandhi Leena | Director | filed 2022 - 2023 |
| Carmer Scott | Director · President and CEO | filed 2021 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Marchio Albert N II | See Remarks | filed 2024 - 2024 |
| Stover Timothy | VP, Corporate Controller | filed 2023 - 2023 |
| Trainer John | Chief Financial Officer | filed 2021 - 2023 |
| Oelke Mathias | Chief Science Officer | filed 2022 - 2023 |
| Zeldis Jerome B | Executive VP of Research & Dev | filed 2021 - 2022 |
| Knight Robert Douglas | Chief Medical Officer | filed 2021 - 2022 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.